Studying endometrial cancer types to predict outcomes
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with endometrioid-type endometrial cancer.
- A tissue sample from your cancer is available for testing.
- You had your surgery at the National Institute of Cancerología (INCan) in Mexico.
- You have not had another cancer in the last 5 years (except certain very early or non-invasive cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks at how people with endometrial cancer manage their care and treatment. It aims to understand your experiences to help improve support for others.
This study is testing whether a special kind of medicine called a PARP inhibitor can work against endometrial cancer cells grown in a lab from your tumor. The goal is to find out which patients might benefit from this treatment in the future.
This study uses tumor tissue and genetic test results to understand which features predict whether lymph nodes (sentinel nodes) are cancer-positive in endometrial (uterine) cancer. It mainly helps doctors improve how they predict spread and tailor care.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
This study creates miniature 3D versions of endometrial cancer tumors (organoids) from tissue samples taken during surgery. The goal is to better understand the disease and find personalized treatments.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.